×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Exact, GE Healthcare to develop ACT ultrasound probe
AuntMinnie
Exact Therapeutics and GE Healthcare are developing an ultrasound probe that will be used to test acoustic cluster therapy (ACT) for multiple diseases in...
8 months ago
XyloCor Therapeutics Positive EXACT Phase 2 Data for Lead Candidate XC001 Simultaneously Presented at Society ...
Business Wire
XyloCor Therapeutics, Inc., a clinical‑stage biopharmaceutical company developing novel gene therapies for cardiovascular disease,...
1 month ago
Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million
Business Wire
Neurogene Inc. (NASDAQ: NGNE) (“Neurogene”), a clinical-stage company founded to bring life-changing genetic medicines to patients and...
5 months ago
Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer
Medical Xpress
Scientists at the Phoenix-based Translational Genomics Research Institute (TGen), part of City of Hope, and EXACT Therapeutics AS...
18 months ago
Opinion: Larimar Could Compete with Biogen in Friedreich’s Ataxia
BioSpace
Phase II data indicate Larimar Therapeutics' injectable therapy nomlabofusp could go head-to-head in the market with Biogen's Skyclarys.
1 month ago
Acoustic Cluster Therapy – A novel ultrasound-mediated drug delivery platform for therapeutic enhancement across ...
Open Access Government
Optimising a drug's ability to reach diseased body parts in adequate levels while avoiding healthy body parts is critical.
23 months ago
Investing in Orbital Therapeutics
Andreessen Horowitz
Orbital is taking advantage of what is already known, but also innovating with urgency to make RNA-based therapeutics impactful and...
13 months ago
Exact bacterial lineage associated with colorectal cancer pinpointed
Drug Target Review
Researchers have discovered two distinct lineages of Fusobacterium nucleatum, which has great implications for colorectal cancer screening...
2 months ago
With Resolution Bio Acquisition, Exact Sciences Takes Aim at NGS-Based Liquid Biopsy Market
GenomeWeb
Industry insiders said Resolution Bio may be a better fit under Exact Sciences and think it could augment Exact's cancer testing portfolio.
8 months ago
Exact Sciences and OncXerna Announce Licensing Agreement to Help Predict Immunotherapy Response for More ...
PR Newswire
PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) and OncXerna Therapeutics, Inc., a precision medicine company, announced today they have...
28 months ago